CLEVELAND, Sept. 30 /PRNewswire/ -- RSB Spine, LLC, today announced that it has signed an exclusive master distribution agreement with Paradigm BioDevices, Inc. for the U.S. market. Paradigm BioDevices was instrumental in developing the Stand Alone 360 market for ZERO-Profile(SM) ALIF implants, which is one of the fastest growing segments in the spine market. RSB Spine's growing portfolio of modular fusion products offers surgeons more choices than existing technologies in the zero profile segment of the market. Moreover, RSB Spine will introduce two new products this year, and two additional products in 2010, making the need for effective distribution critical to the ongoing success of the company.
RSB Spine Chief Executive Officer John A. Redmond said: "We are delighted with this partnership and believe that Paradigm BioDevices' proven success and expertise in this market will greatly enhance our efforts to bring unique, surgeon-friendly implants to RSB's customers. Distribution is one of the most difficult aspects of this business, and we are confident that Paradigm BioDevices will provide increased opportunities for access to quality agents and rapid sales growth."
Paradigm BioDevices, Inc., Chief Executive Officer Mike O'Neill said: "RSB's product portfolio is a truly innovative and remarkable platform that offers surgeons the ability to select material and mechanical properties that best meet their patients' individual needs. We are excited to be involved with RSB's unique products and the diverse market opportunity they afford."
RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products.
Paradigm BioDevices is a privately held manufacturer and distributor of minimally invasive tissue collection systems and novel spinal implant technologies. The company, founded in 1997, is based in Boston and has a U.S. distribution network of 68 agents and more than 250 representatives.
SOURCE RSB Spine, LLC
|SOURCE RSB Spine, LLC|
Copyright©2009 PR Newswire.
All rights reserved